LESSON 5. Counseling clients about DMPA and Sayana Press

Similar documents
LESSON 9. How to counsel clients on Sayana Press self-injection

The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings.

Informed Consent Flipchart. Version 1.0, 30 Jan 2018

Contraception for Adolescents: What s New?

Welcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S.

FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system)

Nelly Mugo, MBChB, MMed, MPH Kenya Medical Research Institute. May 2015

Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE

LONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables

Contraceptives. Kim Dawson October 2010

How to use WHO's family planning guidelines and tools

Family Planning UNMET NEED. The Nurse Mildred Radio Talk Shows

Medical Eligibility for Contraception Use

Contraception for Women and Couples with HIV. Knowledge Test

Expanding Access to Birth Control: Will Women Get the Care They Need?

Information for Informed Consent for Insertion of a Mirena IUD

WHAT ARE CONTRACEPTIVES?

Chapter 6. Client-Provider Interactions: Discussing Side Effects

Contraception Effective Methods of Birth Control

What?! Why?! Emergency Contraception. physical consequences. emotional consequences

Subcutaneous DMPA: Evidence, experience, and resources for introduction

Section 10 Counseling Considerations

What s New in Adolescent Contraception?

Cue Cards for Counseling Adolescents on Contraception

Expanding access to injectable contraceptives

Global Contraception

PROTECT YOURSELF + PROTECT YOUR PARTNER. trichomoniasis THE FACTS

CURRENT HORMONAL CONTRACEPTION - LIMITATIONS

Table I. Examples of Hormone and Tapering Regimens

Contraceptive Technology and Reproductive Health Series: Barrier Methods Post-test

Contraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital

Remind me, what s an STI? And why are they relevant to me?

100% Highly effective No cost No side effects

PREVENTING PREGNANCY: TALKING ABOUT AND USING CONTRACEPTION

Levonorgestrel Intrauterine Device

9p1 Identify the factors that contribute to positive relationships with others. 9p6 Describe the factors that lead to responsible sexual relationships

Can you imagine reversible birth control that s more than 99% effective and 100% hormone free, too?

Expanding Access to Injectable Contraception Geneva, June 2009

The following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that

Birth Control Options Chart

Hormonal Contraception and HIV: The WHO Responds. Ward Cates MTN Annual Meeting February 21, 2012

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use

Family Planning and PMTCT Services for Adolescents

Hormonal Contraception and HIV Acquisition: Getting on the Same Page. Zambia October 2015

Instruction for the patient

Contraception and Kidney Problems: Advice for Young Adults

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study Questions and Answers

Introduction and Instructions

Contraception and gynecological pathologies

Emergency Contraception THE FACTS

Family Planning and Sexually Transmitted. Infections, including HIV

BIRTH CONTROL METHOD COMPARISON CHART

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial

Notes to Teacher continued Contraceptive Considerations

Options in HIV Prevention A Participant-Centered Counseling Approach

Counselling Should: Recognize that behaviour change is difficult and human beings are not perfect

Transcervical Sterilization

FAMILY PLANNING AND SEXUALLY TRANSMITTED INFECTIONS INCLUDING HIV. Unit 20. Learning Objectives. Teaching Resources in this Unit

LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common

Hormonal contraception and HIV risk

Fertility control: what do women want?

LARC. sample. ask brook about. Are any of them right for me? How effective is it? How long does it last? long acting reversible contraception

Impact of Learning HIV Status on Contraceptive Use in the MIRA Trial

Trust Women Seattle Client Information for Informed Consent MASCULIZING MEDICATIONS FOR TRANSGENDER CLIENTS

SIDE EFFECT MANAGEMENT

Section 11. Counseling Procedures

Percentage of family planning clinics, according to clinic characteristics, by service focus, Title X funding status and clinic type, 2010 and 2015

PRECONCEPTION COUNSELING

Essure By Mayo Clinic staff

More info: Your doctor needs to prescribe oral contraceptive pills and will talk to you about the options that are best for you.

For People Who Have Been Sexually Assaulted... What You Need To Know about STDs and Emergency Contraception

Choosing Life: Empowerment, Action, Results! CLEAR Menu Sessions. Health Care 3: Partnering In My Care and Treatment

UW MEDICINE PATIENT EDUCATION. In Vitro Fertilization How to prepare and what to expect DRAFT

Choices TABLE OF CONTENTS

WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT OGEN (AN ESTROGEN HORMONE)?

Update on the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial

Disclosures. Learning Objectives 4/18/2017 ADOLESCENT CONTRACEPTION UPDATE APRIL 28, Nexplanon trainer for Merck

Teen Sexual Health Survey

DEPO-PROVERA/DEPO-PROVERA-SC (medroxyprogesterone acetate) - Product Monograph Page 55 of 61

Strategic Communication for Hormonal Contraception and HIV: An Evidence Review

Examining Long-Acting Reversible Contraceptive Methods

Patient Guide Levonorgestrel and Ethinyl Estradiol Tablets USP (0.1 mg/0.02 mg) and Ethinyl Estradiol Tablets USP (0.

Contraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014

HIV PrEP in Ireland. Information booklet for people who are accessing PrEP themselves or are considering accessing PrEP

A Teacher s Guide Sexually

Acute Salpingitis. Fallopian Tubes. Uterus

LEARNER OUTCOME 1 W-9.12:

POLICY & PROCEDURE DEFINITIONS: N/A POLICY:

LET S TALK about How do you let your partners know they have been exposed to HIV?

Session 6: Related Reproductive Health Needs and Other Issues. Objectives. Training Methods. Materials. Advance Preparation

I M ENDING HIV PATIENT INFORMATION. endinghiv.org.au/prep

HIV and contraception the latest recommendations

Topic 7 Sexual & Reproductive Health

Get Real: Comprehensive Sex Education That Works Logic Model: Snapshot

LARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures

Contraceptive case studies. Dr Christine Roke National Medical Advisor Family Planning June 2015

One-day Essentials Contraception. Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire

Transcription:

LESSON 5 Counseling clients about DMPA and Sayana Press 1

LESSON 5 Learning objectives List possible side effects of DMPA. Describe what to do if a client has concerns or is experiencing side effects. Identify key counseling messages that should be given at injection visits. 2

Counseling is important A client might stop using DMPA if she does not get counseling every time she gets an injection. Women who receive counseling about side effects, especially bleeding changes, are more likely to continue using DMPA. Listen carefully to the client s concerns and give her information or referrals as needed. 3

Counseling helps clients continue use 4 Bleeding changes are the most common reason women stop using injectables. Reassure your client that changes are normal. If she has any serious problems, concerns, or heavy vaginal bleeding and you are not trained to treat this, give her a referral to the appropriate care. Tell her to tell the provider that she received DMPA. Seems like my period just ended and now I m spotting

Side effects of DMPA Prolonged or heavy vaginal bleeding, irregular bleeding, or spotting Amenorrhea (no bleeding) Headaches and dizziness 5 Weight gain Changes in mood and sex drive Abdominal bloating and discomfort

Key counseling messages for the client (part 1) Messages to give women at every injection visit: Do not massage the injection site. Skin may be irritated where injected for a few days. Return for your next injection on time no more than 2 weeks early or 4 weeks late. 6

Key counseling messages for the client (part 2) If you have any problems or concerns or very heavy vaginal bleeding, see me or. (Provide referral information if needed.) Tell the provider that you received Sayana Press. If the client is switching between Sayana Press and depo-im: Sayana Press and depo-im are equally effective. You might have a slight change in vaginal bleeding. 7

HIV and STI prevention Explain to clients that hormonal family planning methods, including DMPA, do not protect a woman from HIV and other STIs. To prevent against STIs, clients should use condoms in addition to DMPA-SC. This is especially important for women at high risk for HIV infection. Offer condoms to your clients for protection against STIs. 8

Potential HIV risk and hormonal methods Some research has found that women who use a progestin-only injectable (POI) like DMPA and are exposed to HIV are slightly more likely than other women to get an HIV infection. However, we do not know whether DMPA causes higher HIV risk. In populations where HIV is common, providers should inform women interested in POIs about these research findings and their uncertainty so they can make an informed choice. 9

Potential HIV risk and hormonal methods Women should not be denied the use of injectables because of concerns about possible increased risk. Women who already have HIV can safely use a POI like DMPA. 10

Potential HIV risk and hormonal methods Where many women are at high risk of HIV infection, consider informing all women interested in DMPA of the following facts: Some research has found that women who use a progestinonly injectable and are exposed to HIV are slightly more likely than other women to get an HIV infection. The meaning of these findings is not clear. We do not know whether or not this method causes this higher HIV risk. You can still choose this method, but we want you to know about this information. We have other equally effective methods and we can discuss them if you would like. It s important that you protect yourself from HIV. 11

Potential HIV risk and hormonal methods 12 If you work in a setting where many women are at high risk of HIV infection, help clients consider: Are you doing something to protect yourself from HIV infection? o Discuss how she protects herself from HIV. If not, could you start protecting yourself now? o Discuss HIV protection choices. Do you like the progestin-only injectable much more than any other method? o If so, reassure her that she can choose a progestin-only injectable if she prefers it. Would you like to discuss and think about other methods, too? o Mention and discuss especially other long-lasting, effective and convenient methods, such as implants and IUDs.

What if my client wants to switch to depo-im? (instructions for referral) It is safe to switch between Sayana Press and depo-im. If your client wants to switch: Ask why she wants to switch. Correct any misunderstandings and make sure that switching will solve the problem. Tell her that side effects will be similar with depo-im. Tell her where she will need to go to get her depo-im injections. If she still wants to switch, give her a referral for depo- IM. Include that she was using Sayana Press, and her reinjection date. 13

What if my client wants to switch to depo-im? (instructions for depo-im providers) It is safe to switch between Sayana Press and depo-im. If your client wants to switch: Ask why she wants to switch. Correct any misunderstandings and make sure that switching will solve the problem. Tell her that side effects will be similar with depo-im. If she still wants to switch, follow the normal procedure for giving a reinjection of depo-im. Make sure that she is within the reinjection window for both products. If not, follow late reinjection procedures. 14

GROUP ACTIVITY Counseling clients Instructions: Review the key counseling messages and instructions for switching in your handout to learn the side effects and counseling messages. Select a partner. Take turns practicing the role of the provider counseling a client interested in Sayana Press. Discuss with the group any issues that come up during the role plays. More information is in the Common Questions about Sayana Press fact sheet. 15

LESSON 5 QUIZ What have you learned about counseling clients? 1. What are some side effects of DMPA? 2. What is the most common reason your client might stop using DMPA, and what can you do to help her with this? 3. What should you do if your client is having one or two side effects but still wants to continue DMPA? 4. What are the key counseling messages that should be given to your clients? 5. Where can you look to find more answers to questions about DMPA and Sayana Press? 16